Compounds > tyrosine

tyrosine and Retinal Diseases

tyrosine has been researched along with Retinal Diseases in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (13.33)	18.7374
1990's	1 (6.67)	18.2507
2000's	6 (40.00)	29.6817
2010's	5 (33.33)	24.3611
2020's	1 (6.67)	2.80

Authors

Authors	Studies
Claesson-Welsh, L; Hedlund, M; Love, DT; Ninchoji, T; Sessa, WC; Smith, RO; Vestweber, D	1
Cadilla, CL; García-Rodríguez, O; Izquierdo, NJ; Jardón, J; Renta, JY	1
Bakunowicz-Łazarczyk, A; Krawczyński, MR; Michalczuk, M; Pawłowski, P; Skorczyk-Werner, A; Warowicka, A; Wawrocka, A; Wicher, K	1
Fu, ZJ; Jang, WC; Li, SY; Lo, AC; Ma, H; So, KF; Wong, D	1
Colhoun, L; Devine, A; Edgar, K; Gardiner, TA; Matesanz, N; McDonald, DM; Stevenson, L	1
Chen, B; Tang, L	1
Bastia, E; Galassi, F; Giambene, B; Impagnatiello, F; Lanzi, C; Masini, E; Ongini, E; Pini, A; Somma, T	1
Koppolu, P; Kowluru, RA	1
Abran, D; Beauchamp, MH; Checchin, D; Chemtob, S; Gobeil, F; Hardy, P; Kermorvant-Duchemin, E; Lachapelle, P; Sennlaub, F; Speranza, G; Varma, DR	1
Inomata, Y; Kawaji, T; Kondo, N; Nakamura, H; Tanihara, H; Tanito, M; Teratani, A; Yodoi, J	1
Amann, T; Apfelstedt-Sylla, E; Felbor, U; Schönherr, U; Stöhr, H; Weber, BH	1
Birch, DG; Bowne, SJ; Daiger, SP; Heckenlively, JR; Lewis, RA; Mintz-Hittner, H; Northrup, H; Rodriquez, JA; Ruiz, RS; Saperstein, DA; Sohocki, MM; Sullivan, LS	1
Courtois, Y; Goureau, O; Sennlaub, F	1
Budzynski, AZ; Marder, VJ	1
Hennekes, R; Lenz, W; Sons, HU; Weber, U	1

Reviews

1 review(s) available for tyrosine and Retinal Diseases

Article	Year
Fundus albipunctatus: review of the literature and report of a novel RDH5 gene mutation affecting the invariant tyrosine (p.Tyr175Phe). Journal of applied genetics, 2015, Volume: 56, Issue:3 Topics: Adolescent; Alcohol Oxidoreductases; Amino Acid Sequence; DNA Mutational Analysis; Female; Humans; Male; Molecular Sequence Data; Night Blindness; Pedigree; Poland; Retinal Diseases; Tyrosine	2015

Other Studies

14 other study(ies) available for tyrosine and Retinal Diseases

Article	Year
eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin. eLife, 2021, 04-28, Volume: 10 Topics: Adherens Junctions; Amino Acid Motifs; Animals; Antigens, CD; Cadherins; Capillary Permeability; CSK Tyrosine-Protein Kinase; Endothelial Cells; Endothelium, Vascular; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Retinal Diseases; Tyrosine; Vascular Endothelial Growth Factor A	2021
Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3). Ophthalmic genetics, 2016, Volume: 37, Issue:1 Topics: Adolescent; Adult; Aged; Carrier Proteins; Child; DNA Mutational Analysis; Exons; Eye Color; Female; Hermanski-Pudlak Syndrome; Humans; Intracellular Signaling Peptides and Proteins; Iris Diseases; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Mutation; Polymerase Chain Reaction; Retinal Diseases; Retrospective Studies; Strabismus; Tyrosine; Vision Disorders; Visual Acuity; Young Adult	2016
Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:2 Topics: Acute Disease; Animals; Antioxidants; Apoptosis; Calbindin 2; Disease Models, Animal; In Situ Nick-End Labeling; Lutein; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; S100 Calcium Binding Protein G; Tyrosine	2009
Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy. Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:6 Topics: Animals; Apoptosis; Arginase; Blotting, Western; Cell Count; Cell Death; Cell Survival; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Nitric Oxide Synthase Type II; Nitrosation; Oxidative Stress; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; Retinal Diseases; Retinal Neurons; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Tyrosine	2010
Protective effects of catalase on retinal ischemia/reperfusion injury in rats. Experimental eye research, 2011, Volume: 93, Issue:5 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Apoptosis; Catalase; Cell Count; Cell Survival; Deoxyguanosine; Dependovirus; Electroretinography; Enzyme-Linked Immunosorbent Assay; Female; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Malondialdehyde; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Retina; Retinal Diseases; Retinal Ganglion Cells; Tyrosine	2011
The nitric oxide donating triamcinolone acetonide NCX 434 does not increase intraocular pressure and reduces endothelin-1 induced biochemical and functional changes in the rabbit eye. The British journal of ophthalmology, 2012, Volume: 96, Issue:5 Topics: Animals; Caspase 3; Cytokines; Electroretinography; Endothelin-1; Glutathione; Hemodynamics; Intraocular Pressure; Intravitreal Injections; Laser-Doppler Flowmetry; Male; Nitrates; Nitric Oxide Donors; Ophthalmic Artery; Optic Disk; Rabbits; Reperfusion Injury; Retina; Retinal Diseases; Superoxide Dismutase; Tonometry, Ocular; Triamcinolone Acetonide; Tyrosine	2012
Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities. Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:10 Topics: Animals; Disease Progression; Drug Administration Schedule; Galactose; Galactosemias; Glutathione; Hexoses; Lipid Peroxides; Male; Metabolic Diseases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Protein Kinase C; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Tyrosine	2002
Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. Free radical biology & medicine, 2004, Dec-01, Volume: 37, Issue:11 Topics: Animals; Animals, Newborn; Antioxidants; Glutathione; Isoenzymes; Malondialdehyde; Metalloporphyrins; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxidation-Reduction; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Retinal Vessels; Salicylates; Tyrosine; Vascular Endothelial Growth Factor Receptor-2	2004
Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. Journal of neurochemistry, 2006, Volume: 98, Issue:2 Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Caspases; Excitatory Amino Acid Agonists; Immunoenzyme Techniques; Immunohistochemistry; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Mitogen-Activated Protein Kinases; N-Methylaspartate; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Retina; Retinal Diseases; Retinal Ganglion Cells; Thioredoxins; Tyrosine	2006
A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy. Journal of medical genetics, 1996, Volume: 33, Issue:3 Topics: Adult; Austria; Base Sequence; Chromosome Mapping; Chromosomes, Human, Pair 22; Cysteine; DNA Primers; Exons; Female; Fundus Oculi; Humans; Male; Molecular Sequence Data; Pedigree; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proteins; Retinal Diseases; Tissue Inhibitor of Metalloproteinase-3; Tyrosine	1996
Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Human mutation, 2001, Volume: 17, Issue:1 Topics: Amino Acid Substitution; Animals; Arginine; Cysteine; Genetic Variation; Glutamine; Homeodomain Proteins; Humans; Intermediate Filament Proteins; Leucine; Membrane Glycoproteins; Mutation; Nerve Tissue Proteins; Optic Atrophies, Hereditary; Peripherins; Prevalence; Proline; Retinal Degeneration; Retinal Diseases; Retinitis Pigmentosa; Rhodopsin; Trans-Activators; Tyrosine	2001
Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, May-15, Volume: 22, Issue:10 Topics: Aging; Amidines; Animals; Animals, Newborn; Apoptosis; Benzylamines; Cell Count; Crosses, Genetic; Diabetic Retinopathy; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxygen; Proteins; Retina; Retinal Diseases; Retinal Vein Occlusion; Tyrosine	2002
Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood. Thrombosis et diathesis haemorrhagica, 1975, Dec-15, Volume: 34, Issue:3 Topics: Amino Acid Sequence; Batroxobin; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Protein Binding; Radioimmunoassay; Retinal Diseases; Retinal Vessels; Thrombophlebitis; Thrombosis; Tyrosine	1975
Experimental calcium oxalate retinopathy compared with cystine- and tyrosine-induced retinal damage. An ophthalmoscopical, histological, and electrophysiological study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1986, Volume: 224, Issue:5 Topics: Animals; Calcium Oxalate; Cystine; Electroretinography; Male; Ophthalmoscopy; Rabbits; Retinal Diseases; Tyrosine	1986